Journal of Pregnancy / 2017 / Article / Tab 1

Clinical Study

Mode of Delivery in Drug-Dependent Pregnant Women: A Case Control Study

Table 1

Maternal characteristics and pregnancy and neonatal outcomes of the study groups.

DD group
()
Non-DD group
()
Odds ratio (95% CI) value

Maternal characteristics
Maternal age (years)28.40 (5.84)29.51 (4.81)0.021
Body mass index (Kg/m2)21.89 (3.73)24.16 (4.27)<0.001
Ethnicity1.463 (0.458–4.679)0.519
 Caucasian231 (97.9)221 (96.9)
Educational level0.130 (0.084–0.202)<0.001
 Low170 (77.6)60 (31.1)
Nulliparous109 (46.2)147 (64.5)0.473 (0.326–0.687)<0.001
Within multiparous
 Previous cesarean section22 (17.3)22 (27.2) 0.562 (0.287–1.100)0.090
 Previous vaginal delivery106 (83.5)59 (72.8)2.002 (1.022–3.922)0.041
Pregnancy complications
Placental abnormalities2 (0.8)3 (1.8)0.641 (0.106–3.872)0.625
Hypertensive complications7 (3.0)5 (2.2)1.363 (0.426–4.359)0.600
Fetal growth restriction48 (20.3)6 (2.6)9.447 (3.955–22.563)<0.001
Labor and neonatal outcomes
Gestational age (weeks)37.97 (1.53)38.83 (31.20)<0.001
Prematurity (<37 weeks)39 (16.6)9 (3.9)4.842 (2.287–10.250)<0.001
 32+0–36+6 weeks35 (14.9)9 (3.9)4.258 (1.997–9.080)<0.001
 28+0–31+6 weeks4 (1.7)00.503 (0.460–0.551)0.124
Fetal presentation0,963 (0.496–1.870)0.912
 Cephalic217 (91.9)209 (91.7)
 Noncephalic19 (8.1)19 (8.3)
Induction of labor58 (24.9)60 (26.3)0.928 (0.611–1.410)0.726
Cesarean section43 (18.2)66 (28.9)0.547 (0.353–0.847)0.006
Newborn birth weight (g)2812.23 (456.59)3180.47 (2812.23)<0.001
 <2500 g61 (25.8)31 (13.6)2.215 (1.374–3.572)0.001
 <1500 g4 (1.7)00.504 (0.460–0.552)0.124
5 min Apgar score <72 (0.8)00.506 (0.463–0.554)0.499

Values are mean (standard deviation) for continuous variables or (%) for categorical variables.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.